Eli Lilly (LLY 1.80%) has been around for almost 150 years, finding ways to innovate and grow. Today, it's the most valuable ...

Seeking more efficient drug development, pharmaceutical giants and startups are encouraging AI fluency and in some cases ...

The vote clears the way for a proposed multibillion-dollar expansion of the former Nexus Pharmaceuticals facility.

Discover why Eli Lilly and Company is set for a strong 2024 with a robust pipeline, solid financials, and strategic growth ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

The company last year opened a $2 billion manufacturing campus that spans more than 1 million square feet and has hundreds of employees. The North Carolina facilities were part of Eli Lilly ...

Eli Lilly is investing an additional $27 billion ... It also said it plans to hire 20,000 new employees. Get a brief on the top business stories of the week, plus CEO interviews, market updates ...

Mounjaro is a very big opportunity, given that a significant number of people have diabetes in India, says the CEO ...

Berenberg Bank analyst Kerry Holford maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) on March 21 and set a price target ...

Shares of Eli Lilly & Co. LLY rallied 3.26% to $864.90 Monday, on what proved to be an all-around great trading session for ...